$MFIN
MEDALLION FINANCIAL CORP Stock $mfin

$mfin Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000156459021024056 Filed on May 05, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$37.08M	$35.54M
YoY Change	4.33%	18.3%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.321M	$1.590M
YoY Change	-16.92%	-22.29%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$8.407M	$9.000M
YoY Change	-6.59%	16.55%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$12.95M	-$16.25M
YoY Change	-179.69%	-1526.69%
Income Tax	$3.878M	-$3.249M
% Of Pretax Income	29.95%
Net Earnings	$8.431M	-$13.64M
YoY Change	-161.8%	-1210.99%
Net Earnings / Revenue	22.74%	-38.39%
Basic Earnings Per Share	$0.34	-$0.56
Diluted Earnings Per Share	$0.34	-$0.56
COMMON SHARES
Basic Shares Outstanding	24.52M	24.40M
Diluted Shares Outstanding	24.90M	24.40M

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$140.3M	$55.50M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$11.90M	$13.90M
YoY Change	-14.39%	4.51%
Goodwill	$150.8M	$150.8M
YoY Change	0.0%	0.0%
Intangibles	$50.73M	$52.18M
YoY Change	-2.77%	-2.69%
Long-Term Investments	$9.500M	$10.30M
YoY Change	-7.77%	18.4%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.689B	$1.534B
YoY Change	10.06%	7.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.800M	$3.300M
YoY Change	45.45%	6.45%
Accrued Expenses	$12.50M	$14.30M
YoY Change	-12.59%	5.15%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due	$73.90M	$60.90M
YoY Change	21.35%
Total Short-Term Liabilities	$91.20M	$93.20M
YoY Change	-2.15%	232.86%
LONG-TERM LIABILITIES
Long-Term Debt	$182.2M	$150.9M
YoY Change	20.74%	-1.18%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$182.2M	$150.9M
YoY Change	20.74%	-1.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$91.20M	$93.20M
Total Long-Term Liabilities	$182.2M	$150.9M
Total Liabilities	$1.449B	$1.284B
YoY Change	12.82%	12.97%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$239.7M	$250.1M
YoY Change
Total Liabilities & Shareholders Equity	$1.689B	$1.534B
YoY Change	10.06%	7.4%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$8.431M	-$13.64M
YoY Change	-161.8%	-1210.99%
Depreciation, Depletion And Amortization	$1.321M	$1.590M
YoY Change	-16.92%	-22.29%
Cash From Operating Activities	$21.06M	$16.79M
YoY Change	25.43%	51.79%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$27.55M	-$34.62M
YoY Change	-20.42%	51.44%
Cash From Investing Activities	-$27.55M	-$34.62M
YoY Change	-20.44%	51.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	34.72M	5.509M
YoY Change	530.31%	-86.3%
NET CHANGE
Cash From Operating Activities	21.06M	16.79M
Cash From Investing Activities	-27.55M	-34.62M
Cash From Financing Activities	34.72M	5.509M
Net Change In Cash	28.24M	-12.32M
YoY Change	-329.12%	-143.38%
FREE CASH FLOW
Cash From Operating Activities	$21.06M	$16.79M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P48M
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2019Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit	2.14
CY2020Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit	2.14
CY2021Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit	2.14
CY2021Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit	2.14
CY2019Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit	13.53
CY2020Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit	12.55
CY2021Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit	12.55
CY2021Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit	15.55
CY2020Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit	4.89
CY2020Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit	7.25
CY2021Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareUpperRangeLimit	7.25
CY2021Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeUpperRangeLimit	7.25
CY2021Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit	7.25
CY2021Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareLowerRangeLimit	6.55
CY2021Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeLowerRangeLimit	6.55
CY2021Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit	4.89
CY2021Q1	mfin	Interest And Dividends On Investment Securities InterestAndDividendsOnInvestmentSecurities	225000
CY2020Q1	mfin	Interest And Dividends On Investment Securities InterestAndDividendsOnInvestmentSecurities	470000
CY2021Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	37080000
CY2020Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	35542000
CY2020Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	243000
CY2021Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	3293000
CY2020Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	2495000
CY2021Q1	us-gaap	Interest Expense InterestExpense	8407000
CY2020Q1	us-gaap	Interest Expense InterestExpense	9000000
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	28673000
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	26542000
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	3019000
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	16541000
CY2021Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	25654000
CY2020Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	10001000
CY2021Q1	mfin	Writedown Of Loan Collateral In Process Of Foreclosure WritedownOfLoanCollateralInProcessOfForeclosure	2785000
CY2020Q1	mfin	Writedown Of Loan Collateral In Process Of Foreclosure WritedownOfLoanCollateralInProcessOfForeclosure	6286000
CY2021Q1	mfin	Income From Sponsorship And Race Winnings IncomeFromSponsorshipAndRaceWinnings	2473000
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1767000
CY2020Q1	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-3510000
CY2021Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	482000
CY2021Q1	us-gaap	Noninterest Income NoninterestIncome	1937000
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	-6980000
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5685000
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6933000
CY2021Q1	mfin	Race Team Related Expense RaceTeamRelatedExpense	2122000
CY2020Q1	mfin	Race Team Related Expense RaceTeamRelatedExpense	2130000
CY2021Q1	mfin	Loan Servicing Fee LoanServicingFee	1647000
CY2020Q1	mfin	Loan Servicing Fee LoanServicingFee	1612000
CY2021Q1	mfin	Collection Costs CollectionCosts	1232000
CY2020Q1	mfin	Collection Costs CollectionCosts	1229000
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	507000
CY2020Q1	us-gaap	Professional Fees ProfessionalFees	3589000
CY2021Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	675000
CY2020Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	697000
CY2021Q1	mfin	Regulatory Fees RegulatoryFees	438000
CY2020Q1	mfin	Regulatory Fees RegulatoryFees	365000
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	361000
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	361000
CY2021Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1975000
CY2020Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	2355000
CY2021Q1	us-gaap	Noninterest Expense NoninterestExpense	14642000
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	19271000
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12949000
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16250000
CY2021Q1	mfin	Income Tax Expense Benefit On Net Investment IncomeTaxExpenseBenefitOnNetInvestment	3878000
CY2020Q1	mfin	Income Tax Expense Benefit On Net Investment IncomeTaxExpenseBenefitOnNetInvestment	-3249000
CY2021Q1	mfin	Net Investment Income Loss After Taxes NetInvestmentIncomeLossAfterTaxes	9071000
CY2020Q1	mfin	Net Investment Income Loss After Taxes NetInvestmentIncomeLossAfterTaxes	-13001000
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	640000
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	642000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	8431000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-13643000
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-605000
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24518775
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24401773
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24895108
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24401773
CY2021Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	325000
CY2020Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	293000
CY2021Q1	mfin	Average Borrowings Outstanding AverageBorrowingsOutstanding	1305162000
CY2020Q1	mfin	Average Borrowings Outstanding AverageBorrowingsOutstanding	1164483000
CY2021Q1	mfin	Weighted Average Cost Of Borrowings WeightedAverageCostOfBorrowings	0.0261
CY2020Q1	mfin	Weighted Average Cost Of Borrowings WeightedAverageCostOfBorrowings	0.0311
CY2021Q1	us-gaap	Profit Loss ProfitLoss	9071000
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-13001000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	147000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	8466000
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12854000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	640000
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	642000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7826000
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13496000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	304561000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	9071000
CY2021Q1	mfin	Distribution To Noncontrolling Interest DistributionToNoncontrollingInterest	-1511000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	498000
CY2021Q1	mfin	Net Change In Unrealized Gains Losses Net Of Tax NetChangeInUnrealizedGainsLossesNetOfTax	-605000
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	312014000
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	334468000
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-13001000
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0
CY2020Q1	mfin	Net Change In Unrealized Gains Losses Net Of Tax NetChangeInUnrealizedGainsLossesNetOfTax	147000
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	320573000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	9071000
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-13001000
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3019000
CY2020Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	16541000
CY2021Q1	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	325000
CY2020Q1	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	293000
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1321000
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1590000
CY2021Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	3620000
CY2020Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-2713000
CY2021Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-1656000
CY2020Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-1304000
CY2021Q1	mfin	Net Change In Loan Collateral In Process Of Foreclosure NetChangeInLoanCollateralInProcessOfForeclosure	-4002000
CY2020Q1	mfin	Net Change In Loan Collateral In Process Of Foreclosure NetChangeInLoanCollateralInProcessOfForeclosure	-8825000
CY2020Q1	mfin	Gain Loss On Sale Of Loans And Investments GainLossOnSaleOfLoansAndInvestments	-3554000
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	498000
CY2020Q1	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	67368000
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	466000
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1767000
CY2021Q1	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-1123000
CY2020Q1	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-125000
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2228000
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-205000
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	944000
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1249000
CY2021Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	126000
CY2020Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-1062000
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	21060000
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16790000
CY2021Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	150598000
CY2020Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	107149000
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	113144000
CY2021Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2000000
CY2020Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	6541000
CY2021Q1	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	8280000
CY2020Q1	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	7692000
CY2021Q1	mfin	Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure	3627000
CY2020Q1	mfin	Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure	4007000
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27547000
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-34623000
CY2021Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	181179000
CY2020Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	114418000
CY2021Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	144944000
CY2020Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	107402000
CY2021Q1	mfin	Distributions To Noncontrolling Interests DistributionsToNoncontrollingInterests	1511000
CY2020Q1	mfin	Distributions To Noncontrolling Interests DistributionsToNoncontrollingInterests	1507000
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	34724000
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5509000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	28237000
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12324000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	112040000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	67821000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	140277000
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	55497000
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	7637000
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	9339000
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4000
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3000
CY2021Q1	mfin	Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure	3802000
CY2020Q1	mfin	Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure	6938000
CY2021Q1	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	8689000
CY2021Q1	mfin	Number Of Medallions NumberOfMedallions	159
CY2021Q1	us-gaap	Reorganization Value Net Realizable Value Of Asset Dispositions ReorganizationValueNetRealizableValueOfAssetDispositions	2298000
CY2020Q4	us-gaap	Reorganization Value Net Realizable Value Of Asset Dispositions ReorganizationValueNetRealizableValueOfAssetDispositions	2932000
CY2020Q1	us-gaap	Reorganization Value Net Realizable Value Of Asset Dispositions ReorganizationValueNetRealizableValueOfAssetDispositions	3091000
CY2021Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P20Y
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.53%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the US, or GAAP, requires management to make estimates that affect the amounts reported in the consolidated financial statements and the accompanying notes. Accounting estimates and assumptions are those that management considers to be the most critical to an understanding of the consolidated financial statements because they inherently involve significant judgments and uncertainties. All of these estimates reflect management’s best judgment about current economic and market conditions and their effects based on information available as of the date of these consolidated financial statements. If such conditions change, it is reasonably possible that the judgments and estimates could change, which may result in future impairments of loans and loan collateral in process of foreclosure, goodwill and intangible assets, and investments, among other effects. </p>
CY2021Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	1500000
CY2021Q1	mfin	Non Marketable Securities NonMarketableSecurities	9529000
CY2020Q4	mfin	Non Marketable Securities NonMarketableSecurities	9746000
CY2021Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-28000
CY2021Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-28000
CY2021Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	43000
CY2020Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	55000
CY2021Q1	mfin	Deferred Loan Origination Costs DeferredLoanOriginationCosts	21618000
CY2020	mfin	Deferred Loan Origination Costs DeferredLoanOriginationCosts	20684000
CY2021Q1	mfin	Amortization Of Loan Origination Fees Net AmortizationOfLoanOriginationFeesNet	-1656000
CY2020Q1	mfin	Amortization Of Loan Origination Fees Net AmortizationOfLoanOriginationFeesNet	-1304000
CY2021Q1	mfin	Financing Receivables Impaired Troubled Debt Restructuring Write Down As Percentage Of Loans FinancingReceivablesImpairedTroubledDebtRestructuringWriteDownAsPercentageOfLoans	0.40
CY2021Q1	us-gaap	Loans Pledged As Collateral LoansPledgedAsCollateral	11020000
CY2020Q4	us-gaap	Loans Pledged As Collateral LoansPledgedAsCollateral	15367000
CY2021Q1	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	106325000
CY2020Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	107131000
CY2021Q1	us-gaap	Goodwill Goodwill	150803000
CY2020Q4	us-gaap	Goodwill Goodwill	150803000
CY2020Q1	us-gaap	Goodwill Goodwill	150803000
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	50729000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	51090000
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52175000
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	361000
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	361000
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	50729000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	51090000
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	84000
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	121000
CY2021Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	645000
CY2020Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	723000
CY2021Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	6523000
CY2020Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	5805000
CY2020Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	4674000
CY2021Q1	mfin	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	8431000
CY2020Q1	mfin	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	-13643000
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24518775
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24401773
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	21168
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	355165
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24895108
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24401773
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1188455
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	807368
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	317398
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	335773
CY2021Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	498000
CY2020Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	466000
CY2021Q1	us-gaap	Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased	0.02
CY2020Q1	us-gaap	Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased	0.02
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4100000
CY2021Q1	mfin	Tier One Leverage Capital Ratio TierOneLeverageCapitalRatio	0.1803
CY2021Q1	us-gaap	Common Equity Tier One Capital Required For Capital Adequacy CommonEquityTierOneCapitalRequiredForCapitalAdequacy	0
CY2021Q1	us-gaap	Common Equity Tier One Capital Required To Be Well Capitalized CommonEquityTierOneCapitalRequiredToBeWellCapitalized	0
CY2021Q1	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	159268000
CY2020Q4	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	148507000
CY2021Q1	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy TierOneRiskBasedCapitalRequiredForCapitalAdequacy	0
CY2021Q1	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized TierOneRiskBasedCapitalRequiredToBeWellCapitalized	0
CY2021Q1	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	228056000
CY2020Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	217295000
CY2021Q1	us-gaap	Capital Required For Capital Adequacy CapitalRequiredForCapitalAdequacy	0
CY2021Q1	us-gaap	Capital Required To Be Well Capitalized CapitalRequiredToBeWellCapitalized	0
CY2021Q1	us-gaap	Capital Capital	244623000
CY2020Q4	us-gaap	Capital Capital	233460000
CY2021Q1	mfin	Average Assets Required For Capital Adequacy AverageAssetsRequiredForCapitalAdequacy	0
CY2021Q1	mfin	Average Assets Required To Be Well Capitalized AverageAssetsRequiredToBeWellCapitalized	0
CY2021Q1	mfin	Average Assets AverageAssets	1265004000
CY2020	mfin	Average Assets AverageAssets	1283664000
CY2021Q1	mfin	Capital Required For Capital Adequacy To Risk Weighted Assets Amount CapitalRequiredForCapitalAdequacyToRiskWeightedAssetsAmount	0
CY2021Q1	mfin	Capital Required To Be Well Capitalized To Risk Weighted Assets Amount CapitalRequiredToBeWellCapitalizedToRiskWeightedAssetsAmount	0
CY2021Q1	us-gaap	Risk Weighted Assets RiskWeightedAssets	1276656000
CY2020Q4	us-gaap	Risk Weighted Assets RiskWeightedAssets	1243783000
CY2021Q1	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	4.0
CY2021Q1	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	5.0
CY2021Q1	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	18.0
CY2020Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	16.9
CY2021Q1	mfin	Common Equity Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.070
CY2021Q1	mfin	Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.065
CY2021Q1	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	12.5
CY2020Q4	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	11.9
CY2021Q1	us-gaap	Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	8.5
CY2021Q1	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	8.0
CY2021Q1	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	17.9
CY2020Q4	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	17.5
CY2021Q1	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	10.5
CY2021Q1	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	10.0
CY2021Q1	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	19.2
CY2020Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	18.8
CY2020	mfin	Tier One Capital Conversation Buffer TierOneCapitalConversationBuffer	0.025
CY2021Q1	mfin	Tier One Capital Conversation Buffer TierOneCapitalConversationBuffer	0.025
CY2021Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain reclassifications have been made to prior year balances to conform with the current year presentation. These reclassifications have no effect on the previously reported results of operations. </p>
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	37284000
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1097000
CY2021Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	300000
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	38081000
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	45155000
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1684000
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	47000
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	46792000
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	20000
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	20000
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	8678000
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	8977000
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	14006000
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	14344000
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	14580000
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	14740000
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	37284000
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	38081000
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	297000
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	9512000
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	3000
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	127000
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	45000
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	4028000
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	2000
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	196000
CY2020Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	57548000
CY2019Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	46093000
CY2021Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	6848000
CY2020Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	11179000
CY2021Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	57809000
CY2021Q1	mfin	Percentage Of Allowance For Loan Losses PercentageOfAllowanceForLoanLosses	1
CY2021Q1	mfin	Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans	0.0459
CY2021Q1	mfin	Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual	1.0161
CY2020Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	57548000
CY2020Q4	mfin	Percentage Of Allowance For Loan Losses PercentageOfAllowanceForLoanLosses	1
CY2020Q4	mfin	Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans	0.0468
CY2020Q4	mfin	Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual	0.9317
CY2021Q1	us-gaap	Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest	56893000
CY2021Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	4090000
CY2020Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	2602000
CY2021Q1	us-gaap	Allowance For Loan And Lease Losses Writeoffs Net AllowanceForLoanAndLeaseLossesWriteoffsNet	2758000
CY2020Q1	us-gaap	Allowance For Loan And Lease Losses Writeoffs Net AllowanceForLoanAndLeaseLossesWriteoffsNet	8577000
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	3019000
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	16541000
CY2021Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	57809000
CY2020Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	54057000
CY2020Q4	us-gaap	Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest	61767000
CY2020Q1	us-gaap	Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest	61635000
CY2021Q1	mfin	Interest Income Foregone On Non Accrual Loans InterestIncomeForegoneOnNonAccrualLoans	578000
CY2020	mfin	Interest Income Foregone On Non Accrual Loans InterestIncomeForegoneOnNonAccrualLoans	2306000
CY2020Q1	mfin	Interest Income Foregone On Non Accrual Loans InterestIncomeForegoneOnNonAccrualLoans	623000
CY2021Q1	mfin	Amount Of Foregone Interest Applied To Principal AmountOfForegoneInterestAppliedToPrincipal	169000
CY2020	mfin	Amount Of Foregone Interest Applied To Principal AmountOfForegoneInterestAppliedToPrincipal	595000
CY2020Q1	mfin	Amount Of Foregone Interest Applied To Principal AmountOfForegoneInterestAppliedToPrincipal	52000
CY2021Q1	mfin	Interest Foregone Life To Date InterestForegoneLifeToDate	5086000
CY2020	mfin	Interest Foregone Life To Date InterestForegoneLifeToDate	5252000
CY2020Q1	mfin	Interest Foregone Life To Date InterestForegoneLifeToDate	3358000
CY2021Q1	mfin	Amount Of Foregone Interest Applied To Principal In Life To Date AmountOfForegoneInterestAppliedToPrincipalInLifeToDate	905000
CY2020	mfin	Amount Of Foregone Interest Applied To Principal In Life To Date AmountOfForegoneInterestAppliedToPrincipalInLifeToDate	792000
CY2020Q1	mfin	Amount Of Foregone Interest Applied To Principal In Life To Date AmountOfForegoneInterestAppliedToPrincipalInLifeToDate	494000
CY2021Q1	us-gaap	Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans	0.05
CY2020Q4	us-gaap	Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans	0.05
CY2020Q1	us-gaap	Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans	0.05
CY2021Q1	mfin	Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans	1.02
CY2020Q4	mfin	Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans	0.93
CY2020Q1	mfin	Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans	0.88
CY2021Q1	us-gaap	Loans And Leases Receivable Loans In Process LoansAndLeasesReceivableLoansInProcess	1259215000
CY2021Q1	mfin	Loans And Leases Receivable Non Performing Percentage LoansAndLeasesReceivableNonPerformingPercentage	0.0455
CY2020Q4	us-gaap	Loans And Leases Receivable Loans In Process LoansAndLeasesReceivableLoansInProcess	1229838000
CY2020	mfin	Loans And Leases Receivable Non Performing Percentage LoansAndLeasesReceivableNonPerformingPercentage	0.0506
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	57282000
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	58029000
CY2021Q1	mfin	Impaired Financing Receivables With Related Allowance Related Allowance ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance	24263000
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	62174000
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	62778000
CY2020Q4	mfin	Impaired Financing Receivables With Related Allowance Related Allowance ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance	25310000
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	62004000
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	62498000
CY2020Q1	mfin	Impaired Financing Receivables With Related Allowance Related Allowance ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance	20333000
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	58660000
CY2021Q1	mfin	Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod	184000
CY2020Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0
CY2020Q4	us-gaap	Federal Home Loan Bank Advances Premium FederalHomeLoanBankAdvancesPremium	2717000
CY2020	mfin	Capitalized Loan Origination Costs CapitalizedLoanOriginationCosts	21345000
CY2021Q1	mfin	Loan To Value Ratio LoanToValueRatio	3.62
CY2020Q4	mfin	Loan To Value Ratio LoanToValueRatio	3.27
CY2020Q1	mfin	Loan To Value Ratio LoanToValueRatio	2.44
CY2020Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	54560000
CY2021Q1	mfin	Loan In Process Of Foreclosure Loans Transfer LoanInProcessOfForeclosureLoansTransfer	3802000
CY2021Q1	mfin	Loan In Process Of Foreclosure Loan Sales LoanInProcessOfForeclosureLoanSales	-2298000
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	64759000
CY2020Q1	mfin	Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod	577000
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	40857000
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	1193548000
CY2021Q1	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	1234405000
CY2021Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0
CY2021Q1	us-gaap	Federal Home Loan Bank Advances Premium FederalHomeLoanBankAdvancesPremium	2530000
CY2021Q1	mfin	Capitalized Loan Origination Costs CapitalizedLoanOriginationCosts	22280000
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	40541000
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	1165235000
CY2020Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	1205776000
CY2021Q1	mfin	Loan In Process Of Foreclosure Loans Cash Payment Received LoanInProcessOfForeclosureLoansCashPaymentReceived	-1329000
CY2021Q1	mfin	Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments LoanInProcessOfForeclosureLoansCollateralValuationAdjustments	-4002000
CY2021Q1	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	50733000
CY2019Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	52711000
CY2020Q1	mfin	Loan In Process Of Foreclosure Loans Transfer LoanInProcessOfForeclosureLoansTransfer	6938000
CY2020Q1	mfin	Loan In Process Of Foreclosure Loan Sales LoanInProcessOfForeclosureLoanSales	-2299000
CY2020Q1	mfin	Loan In Process Of Foreclosure Loans Cash Payment Received LoanInProcessOfForeclosureLoansCashPaymentReceived	-1708000
CY2020Q1	mfin	Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments LoanInProcessOfForeclosureLoansCollateralValuationAdjustments	-8825000
CY2020Q1	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	46817000
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	472033000
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	250163000
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	231815000
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	128617000
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	178781000
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	85100000
CY2021Q1	mfin	Debt Long Term And Short Term Funds Borrowed Amount DebtLongTermAndShortTermFundsBorrowedAmount	1346509000
CY2020Q4	mfin	Debt Long Term And Short Term Funds Borrowed Amount DebtLongTermAndShortTermFundsBorrowedAmount	1312005000
CY2021Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0243
CY2021Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	6523000
CY2020Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	5805000
CY2021Q1	mfin	Reserve Deposits ReserveDeposits	250000
CY2020Q4	mfin	Reserve Deposits ReserveDeposits	250000
CY2021Q1	mfin	Number Of Individual With Time Deposits Greater Than100000 NumberOfIndividualWithTimeDepositsGreaterThan100000	0
CY2021Q1	mfin	Listing Services Deposits From Other Financial Institutions ListingServicesDepositsFromOtherFinancialInstitutions	4036000
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2048000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2004000
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10464000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11018000
CY2021Q1	us-gaap	Time Deposits100000 Or More TimeDeposits100000OrMore	1086485000
CY2020Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	25000000
CY2020Q3	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	250000
CY2020Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2020Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-09-24
CY2020Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	16500000
CY2020Q3	mfin	Remaining Amount Of Debenture After Deducting Leverage Fee RemainingAmountOfDebentureAfterDeductingLeverageFee	8250000
CY2021Q1	mfin	Line Of Credit Facility Drawn Amount LineOfCreditFacilityDrawnAmount	0
CY2021Q1	us-gaap	Contractual Maturities Time Deposits100000 Or More Three Months Or Less ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsOrLess	137602000
CY2021Q1	us-gaap	Contractual Maturities Time Deposits100000 Or More Three Months Through Six Months ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsThroughSixMonths	108194000
CY2021Q1	us-gaap	Contractual Maturities Time Deposits100000 Or More Six Months Through12 Months ContractualMaturitiesTimeDeposits100000OrMoreSixMonthsThrough12Months	152300000
CY2021Q1	us-gaap	Contractual Maturities Time Deposits100000 Or More After12 Months ContractualMaturitiesTimeDeposits100000OrMoreAfter12Months	688389000
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1767000
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	572000
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	596000
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	675000
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	692000
CY2021Q1	mfin	Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	-18000
CY2020Q1	mfin	Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	-14000
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11244000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11737000
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2390000
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	12512000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	13022000
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y1M6D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y4M24D
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0554
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0554
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1849000
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2406000
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2356000
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2373000
CY2021Q1	mfin	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	3521000
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14895000
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2383000
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	12512000
CY2021Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	44662000
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	44799000
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	19275000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	19556000
CY2021Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27847000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	30493000
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	717000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	1174000
CY2021Q1	mfin	Deferred Tax Liabilities Unrealized Loss On Other Investments DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments	6243000
CY2020Q4	mfin	Deferred Tax Liabilities Unrealized Loss On Other Investments DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments	6769000
CY2021Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3066000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	345000
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	462000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	462000
CY2021Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3528000
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	807000
CY2021Q1	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	859000
CY2020	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	1757000
CY2021Q1	mfin	Deferred Tax Assets Liabilities DeferredTaxAssetsLiabilities	-2669000
CY2020Q4	mfin	Deferred Tax Assets Liabilities DeferredTaxAssetsLiabilities	950000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3878000
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3249000
CY2021Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	170000
CY2020Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	86000
CY2021Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3053000
CY2020Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2525000
CY2021Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	655000
CY2020Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-810000
CY2020Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2719000
CY2020Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3412000
CY2021Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	532000
CY2020Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-638000
CY2021Q1	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	170000
CY2020Q1	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	46000
CY2021Q1	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-200000
CY2020Q1	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	378000
CY2021Q1	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	219000
CY2020Q1	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	-216000
CY2021Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	172000
CY2020Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	214000
CY2021Q1	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	704000
CY2020Q1	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-53000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3878000
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3249000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1264315
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	361363
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0097
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0146
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5398
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5018
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	550040
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.58
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	444557
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.24
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	42928
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6.91
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2020	mfin	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	951669
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.41
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	317398
CY2021Q1	mfin	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice	6.79
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.79
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	3984
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6.89
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	768
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.79
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1264315
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.50
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	361363
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.50
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	789000
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	282000
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y9M
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y8M23D
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	773362
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	6.42
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	317398
CY2021Q1	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Grants In Period Exercise Price Per Share ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsGrantsInPeriodExercisePricePerShare	6.79
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.79
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	2530
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	6.96
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	185278
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	6.67
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	902952
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	6.50
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	48000
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	6
CY2021Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4
CY2021Q1	mfin	Number Of Non Operating Segments NumberOfNonOperatingSegments	2
CY2021Q1	mfin	Interest Income Expense Operating InterestIncomeExpenseOperating	37080000
CY2021Q1	mfin	Interest Expense Net InterestExpenseNet	8407000
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	28673000
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	3019000
CY2021Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	25654000
CY2021Q1	mfin	Income From Sponsorship And Race Winnings IncomeFromSponsorshipAndRaceWinnings	2473000
CY2021Q1	mfin	Race Team Related Expense RaceTeamRelatedExpense	2122000
CY2021Q1	mfin	Non Interest Expense Income NonInterestExpenseIncome	13056000
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12949000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3878000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	9071000
CY2021Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1201406000
CY2021Q1	us-gaap	Assets Assets	1688750000
CY2021Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1346759000
CY2021Q1	mfin	Return On Average Assets Percentage ReturnOnAverageAssetsPercentage	0.0208
CY2021Q1	mfin	Percentage Of Return On Average Equity PercentageOfReturnOnAverageEquity	0.1109
CY2021Q1	mfin	Interest Yield InterestYield	0.1184
CY2021Q1	mfin	Net Interest Margin NetInterestMargin	0.0918
CY2021Q1	mfin	Reserve Coverage Ratio ReserveCoverageRatio	0.0459
CY2021Q1	mfin	Delinquency Status DelinquencyStatus	0.0033
CY2021Q1	mfin	Chargeoffs To Loans Percentage ChargeoffsToLoansPercentage	0.0095
CY2020Q1	mfin	Interest Income Expense Operating InterestIncomeExpenseOperating	35542000
CY2020Q1	mfin	Interest Expense Net InterestExpenseNet	9000000
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	26542000
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	16541000
CY2020Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	10001000
CY2020Q1	mfin	Income From Sponsorship And Race Winnings IncomeFromSponsorshipAndRaceWinnings	2573000
CY2020Q1	mfin	Race Team Related Expense RaceTeamRelatedExpense	2130000
CY2020Q1	mfin	Non Interest Expense Income NonInterestExpenseIncome	26694000
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3249000
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-13001000
CY2020Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1129722000
CY2020Q1	us-gaap	Assets Assets	1534395000
CY2020Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1176645000
CY2020Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1172290000
CY2020Q4	us-gaap	Assets Assets	1642411000
CY2020Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1312255000
CY2020Q1	mfin	Return On Average Assets Percentage ReturnOnAverageAssetsPercentage	-0.0357
CY2020Q1	mfin	Percentage Of Return On Average Equity PercentageOfReturnOnAverageEquity	-0.1656
CY2020Q1	mfin	Interest Yield InterestYield	0.1182
CY2020Q1	mfin	Net Interest Margin NetInterestMargin	0.0880
CY2020Q1	mfin	Reserve Coverage Ratio ReserveCoverageRatio	0.0457
CY2020Q1	mfin	Delinquency Status DelinquencyStatus	0.0060
CY2020Q1	mfin	Chargeoffs To Loans Percentage ChargeoffsToLoansPercentage	0.0308
CY2021Q1	mfin	Employment Agreement Description EmploymentAgreementDescription	Employment agreements expire at various dates through 2025
CY2021Q1	mfin	Employment Agreements Future Minimum Payments Due EmploymentAgreementsFutureMinimumPaymentsDue	10720000
CY2021Q1	us-gaap	Trading Liabilities Fair Value Disclosure TradingLiabilitiesFairValueDisclosure	13000
CY2020Q4	us-gaap	Trading Liabilities Fair Value Disclosure TradingLiabilitiesFairValueDisclosure	336000
CY2021Q1	mfin	Net Change In Unrealized Gains Losses Net Of Tax NetChangeInUnrealizedGainsLossesNetOfTax	-605000
CY2020	mfin	Net Change In Unrealized Gains Losses Net Of Tax NetChangeInUnrealizedGainsLossesNetOfTax	-1013000
CY2018Q4	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss	25325000

Files In Submission

Name	View Source	Status
0001564590-21-024056-index-headers.html	Edgar Link	pending
0001564590-21-024056-index.html	Edgar Link	pending
0001564590-21-024056.txt	Edgar Link	pending
0001564590-21-024056-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mfin-10q_20210331.htm	Edgar Link	pending
mfin-10q_20210331_htm.xml	Edgar Link	completed
mfin-20210331.xsd	Edgar Link	pending
mfin-20210331_cal.xml	Edgar Link	unprocessable
mfin-20210331_def.xml	Edgar Link	unprocessable
mfin-20210331_lab.xml	Edgar Link	unprocessable
mfin-20210331_pre.xml	Edgar Link	unprocessable
mfin-ex311_7.htm	Edgar Link	pending
mfin-ex312_6.htm	Edgar Link	pending
mfin-ex321_8.htm	Edgar Link	pending
mfin-ex322_9.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MFIN
MEDALLION FINANCIAL CORP Stock $mfin

2021 Q1 Form 10-Q Financial Statement

#000156459021024056 Filed on May 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MFIN MEDALLION FINANCIAL CORP Stock $mfin

2021 Q1 Form 10-Q Financial Statement

#000156459021024056 Filed on May 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MFIN
MEDALLION FINANCIAL CORP Stock $mfin